US FDA panel gives thumbs down on approval for Amgen lung cancer drug
Advisers to the U.S. Food and Drug Administration on Thursday found that data from a late-stage trial was not reliable enough to support traditional approval of Amgen’s AMGN....
Stay up to date with the latest health news, wellness advice, medical research, and public health updates in Cyprus and around the world.